Asset Details
Do you wish to reserve the book?
Role of the tumor-associated trypsin inhibitor SPINK1 in cancer development
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Role of the tumor-associated trypsin inhibitor SPINK1 in cancer development
Do you wish to request the book?
Role of the tumor-associated trypsin inhibitor SPINK1 in cancer development
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Role of the tumor-associated trypsin inhibitor SPINK1 in cancer development
2011
Overview
In most industrialized countries, prostate cancer is the most common non-skin cancer of men. When detected early, most cases are curable, but for tumors that have metastasized, there is no curative therapy. Pharmaceutical androgen ablation or castration induces remission in most patients with metastatic disease, but if the patient lives long enough, the tumor becomes androgenindependent. In some patients, chemotherapy induces remission, which mostly is of short duration. Therefore, new treatment modalities are needed for androgen-independent prostate cancer.
